What is Youcare Pharmaceutical Group Co., Ltd.'s (688658.SS) StockRank?

MoatMap's StockRank for Youcare Pharmaceutical Group Co., Ltd. (688658.SS) is 39/100, with a Hold signal. This is a composite score combining Quality (47), Value (55), and Momentum (28) factor ranks across MoatMap's 19,000+ stock universe.

Does Youcare Pharmaceutical Group Co., Ltd. have an economic moat?

Youcare Pharmaceutical Group Co., Ltd. (688658.SS) has a Quality factor score of 47/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Youcare Pharmaceutical Group Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Youcare Pharmaceutical Group Co., Ltd. (688658.SS) is Hold, based on a StockRank of 39/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Youcare Pharmaceutical Group Co., Ltd. in?

Youcare Pharmaceutical Group Co., Ltd. (688658.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688658.SS

HOLDREMOVE

Youcare Pharmaceutical Group Co., Ltd. · Healthcare · China · $1.2B · Avg Vol: $24M/d

StockRank

P/E (TTM)

—

ROE

-7.7%

D/E

0.2x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Youcare Pharmaceutical Group lacks the global scale, validated manufacturing facilities, and regulatory moats required to capitalize on the high-conviction CDMO pricing power cycle.

COMPANY DESCRIPTION

Youcare Pharmaceutical Group Co., Ltd. is a vertically integrated pharmaceutical company engaged in the R&D, manufacture, and sale of chemical drugs, APIs, and modern Chinese medicines. The company holds a dominant market share in China's cardiovascular therapeutic segment, driven by its flagship Ginkgo biloba formulations. Its extensive distribution network and robust pipeline of innovative small-molecule drugs support its long-term growth.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	671M	620M	559M	362M	-18.6%
EPS	0.11	0.06	0.04	-0.09	-38.5%
Shares	450M	450M	450M	450M	0.0%
Debt	41M	68M	104M	90M	29.9%
Equity	590M	530M	529M	490M	-6.0%
Op CF	-18M	116M	65M	50M	-34.2%
Inv CF	-82M	-74M	-81M	-69M	—
Fin CF	-15M	-64M	-4M	-17M	—

PRICE (1M)-31.6%

SMA 50SMA 200

$1.98

RSI (14)

4.9

52W High

$5.39

From 52W High

0.4%

SCORE BREAKDOWN

Quality

ROIC

-6.1%38.0

ROE

-7.7%37.1

GP/Assets

24.1%54.6

Op. Margin

-3.0%33.1

FCF/Assets

6.0%74.7

Piotroski

—55.8

Int. Cover

-9.9x24.7

D/E Ratio

0.17x55.5

Current Ratio

1.97x36.2

Value

P/E (TTM)

—N/A

EV/EBITDA

-375.3x98.9

P/FCF

175.0x59.3

P/B

1.9x56.8

P/S

2.5x61.4

Div Yield

—N/A

Momentum

52W High %

37%9.8

RS 6M

-54%19.8

SMA 50/200

0.83x17.5

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+173%84.7

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$1.2B

P/E (Forward)

33.5x

Gross Margin

51.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688658.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688658.SS	Youcare Pharmaceutical Group Co., Ltd.(you)	$1.2B	39	HOLD
2171.HK	CARsgen Therapeutics Holdings Limited	$1.3B	39	HOLD
300497.SZ	Jiangxi Fushine Pharmaceutical Co., Ltd.	$1.2B	41	HOLD
603229.SS	Zhejiang Ausun Pharmaceutical Co., Ltd.	$1.2B	43	HOLD
301080.SZ	Acrobiosystems Co.,Ltd.	$1.0B	38	HOLD
688739.SS	Liaoning Chengda Biotechnology Co.,Ltd.	$1.3B	42	HOLD
688767.SS	Hangzhou Biotest Biotech Co.,Ltd.	$842M	39	HOLD
9887.HK	Nanjing Leads Biolabs Co., Ltd.	$1.6B	37	HOLD
600866.SS	Star Lake Bioscience Co., Inc.Zhaoqing Guangdong	$1.2B	46	HOLD
688293.SS	Shanghai OPM Biosciences Co., Ltd.	$898M	42	HOLD

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.1%

Youcare Pharmaceutical Group Co., Ltd. (688658.SS) — Stock Score Summary

Youcare Pharmaceutical Group Co., Ltd. (688658.SS) has a MoatMap StockRank of 39/100 based on Quality (47/100), Value (55/100), and Momentum (28/100) factor scores. The current signal is HOLD. Youcare Pharmaceutical Group lacks the global scale, validated manufacturing facilities, and regulatory moats required to capitalize on the high-conviction CDMO pricing power cycle.

Key Financial Metrics

Price	$1.98
Market Cap	$1.2B
P/E (Forward)	33.50
Price/Book	1.93
Return on Equity	-7.7%
Return on Invested Capital	-6.1%
Debt/Equity	17.30
Gross Margin	51.4%
Operating Margin	-3.0%
Revenue Growth	-3.7%
Free Cash Flow	$7M

Youcare Pharmaceutical Group Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Youcare Pharmaceutical Group Co., Ltd.’s (688658.SS) StockRank?: MoatMap’s StockRank for Youcare Pharmaceutical Group Co., Ltd. (688658.SS) is 39/100, with a Hold signal. It is a composite of Quality (47), Value (55), and Momentum (28) factor ranks across MoatMap’s 19,000+ stock universe.
Does Youcare Pharmaceutical Group Co., Ltd. have an economic moat?: Youcare Pharmaceutical Group Co., Ltd. (688658.SS) has a Quality factor score of 47/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Youcare Pharmaceutical Group Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Youcare Pharmaceutical Group Co., Ltd. (688658.SS) is Hold, based on a StockRank of 39/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Youcare Pharmaceutical Group Co., Ltd. in?: Youcare Pharmaceutical Group Co., Ltd. (688658.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).